NASDAQ:BVXV - BIONDVAX PHARMA/S News Headlines

Sign in or create an account to add this stock to your watchlist.
$7.00 -0.09 (-1.27 %)
(As of 04/26/2019 10:43 AM ET)
Previous Close$7.0899
Today's Range$7.00 - $7.0001
52-Week Range$3.51 - $7.26
Volume2,555 shs
Average Volume6,966 shs
Market Capitalization$45.75 million
P/E RatioN/A
Dividend YieldN/A
Beta1.18

Headlines

BIONDVAX PHARMA/S (NASDAQ BVXV) News Headlines

Source:
DateHeadline
Comparing bluebird bio (BLUE) & BIONDVAX PHARMA/S (BVXV)Comparing bluebird bio (BLUE) & BIONDVAX PHARMA/S (BVXV)
www.americanbankingnews.com - April 22 at 6:15 AM
BVXV: Update on Phase 3 Clinical Trial of Universal Influenza Vaccine…BVXV: Update on Phase 3 Clinical Trial of Universal Influenza Vaccine…
finance.yahoo.com - April 17 at 5:13 PM
Atara Biotherapeutics (ATRA) vs. BIONDVAX PHARMA/S (BVXV) Critical ReviewAtara Biotherapeutics (ATRA) vs. BIONDVAX PHARMA/S (BVXV) Critical Review
www.americanbankingnews.com - April 15 at 10:19 PM
BiondVax Universal Flu Vaccine Patent Application Accepted in AustraliaBiondVax Universal Flu Vaccine Patent Application Accepted in Australia
finance.yahoo.com - April 15 at 10:12 AM
BiondVax to Provide Update of M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial at IVW2019 ConferenceBiondVax to Provide Update of M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial at IVW2019 Conference
finance.yahoo.com - March 28 at 10:46 AM
BiondVax CEO to Present at World Vaccine Congress 2018 San Diego About BiondVaxs Phase 3 Universal Flu Vaccine CandidateBiondVax CEO to Present at 'World Vaccine Congress 2018 San Diego' About BiondVax's Phase 3 Universal Flu Vaccine Candidate
finance.yahoo.com - November 26 at 9:54 AM
BVXV: Enrollment of First Season Cohort Complete in Phase 3 Trial of Universal Influenza Vaccine…BVXV: Enrollment of First Season Cohort Complete in Phase 3 Trial of Universal Influenza Vaccine…
finance.yahoo.com - November 20 at 4:10 PM
BiondVax Issues Clarification Regarding Third Quarter 2018 Financial ResultsBiondVax Issues Clarification Regarding Third Quarter 2018 Financial Results
finance.yahoo.com - November 19 at 9:44 AM
BiondVax Announces Third Quarter 2018 Financial ResultsBiondVax Announces Third Quarter 2018 Financial Results
finance.yahoo.com - November 13 at 4:09 PM
BiondVaxs Universal Flu Vaccine Phase 3 Clinical Trial Completes First Seasons Enrollment of 4,098 ParticipantsBiondVax's Universal Flu Vaccine Phase 3 Clinical Trial Completes First Season's Enrollment of 4,098 Participants
finance.yahoo.com - October 24 at 9:56 AM
BiondVax Receives €8M From the European Investment Bank (EIB) in Support of Manufacturing Facility and Ongoing Phase 3 Clinical TrialBiondVax Receives €8M From the European Investment Bank (EIB) in Support of Manufacturing Facility and Ongoing Phase 3 Clinical Trial
finance.yahoo.com - October 22 at 9:50 AM
BVXV: Phase 3 Trial of M-001 Underway…BVXV: Phase 3 Trial of M-001 Underway…
finance.yahoo.com - September 5 at 10:02 AM
BiondVax to Present at Influenza 2018 Oxford ConferenceBiondVax to Present at Influenza 2018 Oxford Conference
finance.yahoo.com - September 4 at 10:08 AM
BiondVax Announces Second Quarter 2018 Financial ResultsBiondVax Announces Second Quarter 2018 Financial Results
finance.yahoo.com - August 22 at 9:58 AM
First Participant Enrolled in BiondVaxs Universal Flu Vaccine Pivotal Phase 3 Clinical TrialFirst Participant Enrolled in BiondVax's Universal Flu Vaccine Pivotal Phase 3 Clinical Trial
finance.yahoo.com - August 8 at 10:02 AM
Corporate Biotech Executive Mark Germain Joins BiondVaxs Board of DirectorsCorporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
finance.yahoo.com - June 28 at 12:20 PM
BiondVax Receives Its First €6M Tranche Disbursement From the European Investment Bank (EIB)BiondVax Receives Its First €6M Tranche Disbursement From the European Investment Bank (EIB)
finance.yahoo.com - June 19 at 12:06 PM
BVXV: Increased Media Coverage for M-001 Ahead of Phase 3 Clinical TrialBVXV: Increased Media Coverage for M-001 Ahead of Phase 3 Clinical Trial
finance.yahoo.com - June 1 at 4:00 PM
BiondVax Announces First Quarter 2018 Financial ResultsBiondVax Announces First Quarter 2018 Financial Results
finance.yahoo.com - May 29 at 9:50 AM
BVXV: Set to Initiate Phase 3 Clinical Trial of Universal Influenza Vaccine Candidate in 2H18BVXV: Set to Initiate Phase 3 Clinical Trial of Universal Influenza Vaccine Candidate in 2H18
finance.yahoo.com - May 7 at 9:49 AM
BiondVax Announces Fourth Quarter and Full Year 2017 Financial Results and UpdateBiondVax Announces Fourth Quarter and Full Year 2017 Financial Results and Update
finance.yahoo.com - May 1 at 9:59 AM
An Ear To The Pharma: 9 Stocks To Watch This Week (RIGL, RARE, TROV, DVAX...)An Ear To The Pharma: 9 Stocks To Watch This Week (RIGL, RARE, TROV, DVAX...)
www.finanznachrichten.de - April 14 at 3:40 PM
BiondVax to Present at Universal Influenza Vaccines ConferenceBiondVax to Present at Universal Influenza Vaccines Conference
finance.yahoo.com - April 12 at 11:01 AM
BiondVax Begins NIH-Sponsored Phase 2 Clinical Trial of Its Universal Flu Vaccine in the United StatesBiondVax Begins NIH-Sponsored Phase 2 Clinical Trial of Its Universal Flu Vaccine in the United States
finance.yahoo.com - April 11 at 10:43 AM
BiondVax Appoints CRO to Conduct Pivotal Clinical Efficacy Phase 3 Trial of Its Novel Universal Flu Vaccine CandidateBiondVax Appoints CRO to Conduct Pivotal Clinical Efficacy Phase 3 Trial of Its Novel Universal Flu Vaccine Candidate
finance.yahoo.com - March 13 at 10:36 AM
BiondVax and European UNISEC Consortium to Host Universal Flu Vaccine ConferenceBiondVax and European UNISEC Consortium to Host Universal Flu Vaccine Conference
finance.yahoo.com - February 8 at 9:18 AM
BiondVax Universal Flu Vaccine Patent Granted in IndiaBiondVax Universal Flu Vaccine Patent Granted in India
finance.yahoo.com - January 2 at 9:49 AM
BiondVax Pharma (BVXV) Announces Plans for Phase 3 Clinical Trial Following Receipt of Scientific Advice from the European Medicines AgencyBiondVax Pharma (BVXV) Announces Plans for Phase 3 Clinical Trial Following Receipt of Scientific Advice from the European Medicines Agency
www.streetinsider.com - December 27 at 10:52 PM
BiondVax Plans Phase 3 Clinical Trial Following Receipt of Scientific Advice from the European Medicines Agency (EMA)BiondVax Plans Phase 3 Clinical Trial Following Receipt of Scientific Advice from the European Medicines Agency (EMA)
finance.yahoo.com - December 27 at 5:51 PM
BVXV: Planning Continues for M-001 Phase 3 Program …BVXV: Planning Continues for M-001 Phase 3 Program …
finance.yahoo.com - December 12 at 5:21 PM
BiondVax Provides Third Quarter 2017 Financial Results and UpdateBiondVax Provides Third Quarter 2017 Financial Results and Update
finance.yahoo.com - November 28 at 4:55 PM
BiondVax Pharma (BVXV) Reports Clinical Trial Agreement with NIH for U.S. Phase 2 Trial of Universal Flu VaccineBiondVax Pharma (BVXV) Reports Clinical Trial Agreement with NIH for U.S. Phase 2 Trial of Universal Flu Vaccine
www.streetinsider.com - November 21 at 5:01 PM
BiondVax Pharmaceuticals’ (BVXV) Quant Score Makes it BuyBiondVax Pharmaceuticals’ (BVXV) Quant Score Makes it Buy
investorplace.com - November 11 at 4:43 PM
BiondVax Pharmaceuticals’ (BVXV) Quant Score Makes it BuyBiondVax Pharmaceuticals’ (BVXV) Quant Score Makes it Buy
investorplace.com - November 10 at 4:43 PM
BVXV: Raises $10 Million to Help Support M-001 Pivotal P3 Program as Standalone Universal Influenza VaccineBVXV: Raises $10 Million to Help Support M-001 Pivotal P3 Program as Standalone Universal Influenza Vaccine
finance.yahoo.com - September 20 at 5:35 PM
BiondVax Announces Closing of $10 Million Public Offering of American Depositary Shares and Exercise of Over-allotment OptionBiondVax Announces Closing of $10 Million Public Offering of American Depositary Shares and Exercise of Over-allotment Option
finance.yahoo.com - September 18 at 5:08 PM
BiondVax Pharma (BVXV) Plans Public Offering of ADSsBiondVax Pharma (BVXV) Plans Public Offering of ADSs
www.streetinsider.com - September 14 at 5:32 PM
BiondVax Announces Pricing of Public Offering of American Depositary SharesBiondVax Announces Pricing of Public Offering of American Depositary Shares
finance.yahoo.com - September 13 at 11:04 PM
Should You Buy BiondVax Pharmaceuticals Ltd (BVXV)?Should You Buy BiondVax Pharmaceuticals Ltd (BVXV)?
finance.yahoo.com - September 13 at 6:03 PM
BiondVax Announces Public Offering of American Depositary SharesBiondVax Announces Public Offering of American Depositary Shares
finance.yahoo.com - September 13 at 6:03 PM
BiondVax Provides Second Quarter 2017 Financial Results and UpdateBiondVax Provides Second Quarter 2017 Financial Results and Update
finance.yahoo.com - August 31 at 4:45 PM
Dual-Listed BiondVax to Voluntarily Delist from Tel Aviv Stock ExchangeDual-Listed BiondVax to Voluntarily Delist from Tel Aviv Stock Exchange
finance.yahoo.com - August 31 at 4:45 PM
BiondVax Receives Additional Grant FundingBiondVax Receives Additional Grant Funding
finance.yahoo.com - August 14 at 5:16 PM
BVXV: Positive Results From Phase 2b Trial of M-001; Ready to Move Into Pivotal P3 Trial as Standalone Universal Influenza VaccineBVXV: Positive Results From Phase 2b Trial of M-001; Ready to Move Into Pivotal P3 Trial as Standalone Universal Influenza Vaccine
finance.yahoo.com - August 1 at 5:38 PM
BiondVax Reports Positive Phase 2b Clinical Trial Results for its Universal Flu VaccineBiondVax Reports Positive Phase 2b Clinical Trial Results for its Universal Flu Vaccine
finance.yahoo.com - July 20 at 6:31 PM
BiondVax Pharma (BVXV) Reports Agreement for Mid-Size Commercial Facility to Manufacture Universal Flu VaccineBiondVax Pharma (BVXV) Reports Agreement for Mid-Size Commercial Facility to Manufacture Universal Flu Vaccine
www.streetinsider.com - July 19 at 6:46 AM
BiondVax Signs Lease Agreement for Mid-Size Commercial Facility to Manufacture Universal Flu VaccineBiondVax Signs Lease Agreement for Mid-Size Commercial Facility to Manufacture Universal Flu Vaccine
finance.yahoo.com - July 18 at 6:21 PM
BVXV: Secures $22 Million Loan Agreement with European Investment Bank…BVXV: Secures $22 Million Loan Agreement with European Investment Bank…
finance.yahoo.com - July 6 at 6:05 PM
BiondVax Pharma (BVXV) Provides H1 General Corporate UpdateBiondVax Pharma (BVXV) Provides H1 General Corporate Update
www.streetinsider.com - June 28 at 9:50 PM
BiondVax Pharmaceuticals (BVXV) Leaps on Israeli NodBiondVax Pharmaceuticals (BVXV) Leaps on Israeli Nod
www.baystreet.ca - March 31 at 9:15 PM
This page was last updated on 4/26/2019 by MarketBeat.com Staff

Featured Article: Green Investing

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel